Newsfile Corp
29 May 2026, 20:30 UTC · 2h ago
Source · https://www.newsfilecorp.com/release/299487/Defence-Therapeutics-Strengthens-Its-Scientific-Advisory-Board-with-the-Appointment-of-Dr.-Sarkis-Meterissian
Read source
Search tags
Story key points
2 claims · impact-rated
Defence Therapeutics granted 150,000 incentive stock options to employees and consultants with an exercise price of 58 cents per share. — This represents a minor potential dilution of equity, though the scale is relatively small.
-0.10Dr. Sarkis Meterissian resigned from the Board of Directors to join the company's Scientific Advisory Board (SAB). — This is a structural shift in a single individual's role from governance to advisory and is unlikely to move the stock price.
+0.00Ticker attribution
Model heads
The company is strengthening its Scientific Advisory Board with a specialized expert and granting incentive options to staff.
Continue reading
6 related stories
No ticker relationship head found.
Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
4h ago
